A double-blind, randomized, placebo-controlled trial was conducted to evaluate the success rate of Helicobacter pylori (H pylori) eradication, improvement of clinical symptoms, and safety of a product containing immunoglobin Y and Lactobacillus johnsonii in supporting the quadruple regime for H pylori infection treatment.